New study illuminates the genetics of thumb arthritis treatment

NewsGuard 100/100 Score

Rhizarthrosis, also known as trapeziometacarpal osteoarthritis, is a type of osteoarthritis that affects the thumb, and treatments range from splints to surgery. Investigators have uncovered various genetic differences between individuals with rhizarthrosis who undergo surgery for their condition versus those who opt for nonsurgical treatments.

The study, which is published in the Journal of Orthopaedic Research, included 1,083 surgical patients and 1,888 nonsurgical patients with rhizarthrosis, as well as 205,371 controls without osteoarthritis.

Researchers identified 7 genetic variants that may be associated with surgical rhizarthrosis and 3 variants suggestively associated with nonsurgical rhizarthrosis. They noted that uncovering genetic differences between these patient groups may reveal biological mechanisms that affect various aspects of rhizarthrosis.

Our findings delve into the genetic architecture of osteoarthritis in the thumb base, hinting at a potential genetic influence on the need for surgery. While no solid conclusions about the effect of specific genetic variants on the need for surgical treatment should be made at this stage, our study marks a stride towards integrating genetic insights into the clinical management of osteoarthritis, with the long-term aim of refining diagnosis, treatment, and preventative strategies for this common and debilitating disease."

Cecilie Henkel, MD, PhD, corresponding author of Copenhagen University Hospital Hvidovre, in Denmark

Journal reference:

Henkel, C., et al. (2024) Genetics may affect the risk of undergoing surgery for rhizarthrosis. Journal of Orthopaedic Research.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ACMG releases new Points to Consider statement on the clinical utility of polygenic risk scores for embryo selection